| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689335 | European Urology | 2017 | 9 Pages |
Abstract
We proposed two models for estimating overall survival of patients with metastatic urothelial carcinoma receiving first-line, platinum-based chemotherapy. These nomograms have been developed on real-world patients who were treated outside of clinical trials and may be used irrespective of the chemotherapeutic platinum agent used.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Andrea Necchi, Guru Sonpavde, Salvatore Lo Vullo, Daniele Giardiello, Aristotelis Bamias, Simon J. Crabb, Lauren C. Harshman, Joaquim Bellmunt, Ugo De Giorgi, Cora N. Sternberg, Linda Cerbone, Sylvain Ladoire, Yu-Ning Wong, Evan Y. Yu, Simon Chowdhury,